ConductScience.org, home

Paper41535685

Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine.

Tognoni CM and 5 others. Sci Rep, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine. Papers, record 41535685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41535685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine.
PubMed
Journal
Sci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-06-27
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tognoni CMChristina M
2Ghosh Biswas RRajshree
3Suar ZMZeynep Melis
4Carreras IIsabel
5Dedeoglu AAlpaslan
6Jenkins BGBruce G

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TaurineMajor topic
Alzheimer DiseaseMajor topic
Dietary SupplementsMajor topic
Neuroprotective AgentsMajor topic
Animals
Mice
Disease Models, Animal
Magnetic Resonance Spectroscopy
Mice, Transgenic
Amyloid beta-Peptides
Male
Cytokines

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG069228NIA NIH HHSUnited StatesR01AG069228PubMedNIH RePORTER
MFE-194064CIHRCanadaPubMedPubMed
RF1 AG069228NIA NIH HHSUnited StatesRF1AG069228PubMedNIH RePORTER
1RF1AG069228 ; 5R01AG070257NIH HHSUnited StatesRF1AG069228PubMedNIH RePORTER
R01 AG070257NIA NIH HHSUnited StatesR01AG070257PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41282082Protection of multiple aspects of Alzheimer's disease pathology using dietary supplementation with taurine.https://conductscience.org/library/papers/41282082

Source PubMed

Download CSV of comments and corrections

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133727609Electronegative very-low-density lipoprotein induces brain inflammation and cognitive dysfunction in mice.Sci Rep2021https://conductscience.org/library/papers/33727609PubMed
236902391Status of Metabolomic Measurement for Insights in Alzheimer's Disease Progression-What Is Missing?Int J Mol Sci2023https://conductscience.org/library/papers/36902391PubMed
329273078Practical considerations for choosing a mouse model of Alzheimer's disease.Mol Neurodegener2017https://conductscience.org/library/papers/29273078PubMed
42089275Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.Neuroscience1990https://conductscience.org/library/papers/2089275PubMed
531358793Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.Sci Rep2019https://conductscience.org/library/papers/31358793PubMed
612552120Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12552120PubMed
723327111Protective effects of taurine against closed head injury in rats.J Neurotrauma2015https://conductscience.org/library/papers/23327111PubMed
828703214Stop Alzheimer's before it starts.Nature2017https://conductscience.org/library/papers/28703214PubMed
923040664CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.Neurobiol Aging2013https://conductscience.org/library/papers/23040664PubMed
107892497Probable Alzheimer disease: diagnosis with proton MR spectroscopy.Radiology1995https://conductscience.org/library/papers/7892497PubMed
1117046788Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.J Mol Biol2006https://conductscience.org/library/papers/17046788PubMed
1221825241The dynamics of cortical and hippocampal atrophy in Alzheimer disease.Arch Neurol2011https://conductscience.org/library/papers/21825241PubMed
1315003996Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.FASEB J2004https://conductscience.org/library/papers/15003996PubMed
1437153279Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review.Cureus2023https://conductscience.org/library/papers/37153279PubMed
1522840748scyllo-Inositol, preclinical, and clinical data for Alzheimer's disease.Adv Pharmacol2012https://conductscience.org/library/papers/22840748PubMed
1633778150Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease.Alzheimers Dement (N Y)2021https://conductscience.org/library/papers/33778150PubMed
1729775591Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration.Cell2018https://conductscience.org/library/papers/29775591PubMed
1828849459Taurine Directly Binds to Oligomeric Amyloid-β and Recovers Cognitive Deficits in Alzheimer Model Mice.Adv Exp Med Biol2017https://conductscience.org/library/papers/28849459PubMed
1932968166Evaluation of the neuroprotective effect of taurine in Alzheimer's disease using functional molecular imaging.Sci Rep2020https://conductscience.org/library/papers/32968166PubMed
202150771Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.Brain Res1990https://conductscience.org/library/papers/2150771PubMed

See all 72 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41893715Canine Cognitive Dysfunction and Alzheimer's Disease: Pathophysiological Relationships and the Impact of Glymphatic System Impairment on Neurodegeneration.Vet Sci2026https://conductscience.org/library/papers/41893715

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
APP351PubTator's text mininghttps://conductscience.org/library/genes/351

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41535685

GET https://conductscience.org/api/papers/v1/41535685/references?page=2